Abbott Laboratories (ABT)

Abbott Laboratories Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 129.8, with a low estimate of 117 and a high estimate of 149. The average target predicts an increase of 13.63% from the current stock price of 114.23.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$117	$129.8	$129	$149
Change	+2.42%	+13.63%	+12.93%	+30.44%

* Price targets were last updated on Nov 5, 2024.

Analyst Ratings

The average analyst rating for ABT stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	3	4	3	4	4	4
Buy	5	5	6	8	8	7
Hold	1	1	2	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	11	16	16	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Miksic Barclays	Barclays	Buy Maintains $143 → $149	Buy	Maintains	$143 → $149	+30.44%	Nov 5, 2024
Lee Hambright Bernstein	Bernstein	Buy Maintains $133 → $138	Buy	Maintains	$133 → $138	+20.81%	Oct 17, 2024
Danielle Antalffy UBS	UBS	Strong Buy Maintains $143 → $146	Strong Buy	Maintains	$143 → $146	+27.81%	Oct 17, 2024
Matthew Taylor Jefferies	Jefferies	Hold Maintains $120 → $125	Hold	Maintains	$120 → $125	+9.43%	Oct 17, 2024
Anthony Petrone Mizuho	Mizuho	Hold Maintains $115 → $130	Hold	Maintains	$115 → $130	+13.81%	Oct 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

42.41B

Increased by 5.73%

from 40.11B

Revenue Next Year

45.45B

Increased by 7.17%

from 42.41B

EPS This Year

4.72

Increased by 44.86%

from 3.26

EPS Next Year

5.21

Increased by 10.40%

from 4.72

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	31.90B	34.61B	43.08B	43.65B	40.11B	42.41B	45.45B	48.80B
Revenue Growth	4.34%	8.48%	24.47%	1.34%	-8.12%	5.73%	7.17%	7.38%
EPS	2.06	2.50	3.94	3.91	3.26	4.72	5.21	5.77
EPS Growth	54.98%	21.53%	57.38%	-0.76%	-16.62%	44.86%	10.40%	10.59%
Forward PE	-	-	-	-	-	24.19	21.91	19.81
No. Analysts	-	-	-	-	-	31	31	27

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	44.3B	47.8B	52.0B
Avg	42.4B	45.4B	48.8B
Low	40.9B	43.5B	46.6B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	10.4%	12.8%	14.4%
Avg	5.7%	7.2%	7.4%
Low	1.9%	2.6%	2.5%

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	4.94	5.52	6.18
Avg	4.72	5.21	5.77
Low	4.57	5.00	5.45

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	51.4%	17.0%	18.6%
Avg	44.9%	10.4%	10.6%
Low	40.1%	5.8%	4.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.